• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,398.31 2,781.73
( 3.73%)
Global Indices
Nasdaq
46,614.19 -76.70
(-0.16%)
Dow Jones
6,639.23 6.40
(0.10%)
Hang Seng
56,345.93 2,916.37
(5.46%)
Nikkei 225
10,352.49 -83.80
(-0.80%)
Forex
USD-INR
92.93 0.25
(0.27%)
EUR-INR
107.23 0.49
(0.46%)
GBP-INR
122.94 0.71
(0.58%)
JPY-INR
0.58 0.00
(0.32%)

EQUITY - MARKET SCREENER

All E Technologies Ltd
Industry :  Computers - Software - Medium / Small
BSE Code
ISIN Demat
Book Value()
77118
INE0M2X01012
66.9034854
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ALLETEC
15.92
384.3
EPS(TTM)
Face Value()
Div & Yield %
11.95
10
0.79
 

Pfizer announces change in senior management
Jan 20,2026

Pfizer announced the following change in senior management:

  • Nilesh Pendse is appointed as Category Lead – Vaccines of the Company with effect from 01 February 2026. Pendse shall accordingly be a Senior Management Personnel of the Company effective the said date.
  • Manikantan Seshadrinathan – Category Lead, Hospitals & Rare Disease will transition to another role within the Pfizer Group Companies effective 01 February 2026, and shall accordingly cease to be a Senior Management Personnel of the Company effective 31 January 2026.
  • Prashant Mahalingam, Category Lead – Internal Medicine, will take up additional responsibility of the Hospitals Business of the Company and shall be redesignated as Category Lead – Internal Medicine & Hospitals, effective 01 February 2026.